Mortaliteten hos svårt njursjuka var hög under covid 19-pandemin

Translated title of the contribution: COVID-19 related mortality in Swedish patients with renal replacement therapy

Mårten Segelmark, Leo Segelmark, Jessica Smolander, Helena Rydell, Marie Evans, Maria Stendahl

Research output: Contribution to journalArticlepeer-review

Abstract

Data from the Swedish Renal Registry (SRR) show that during the period March 16, 2020 to March 15, 2021 0.4% of all renal transplant recipients and 3% of all dialysis patients died due to COVID-19 in Sweden. Of all registered deaths, 20% were attributed to COVID-19.  In the age group 50-59 years the risk ratio for COVID-19 related mortality was 16 (95% CI 6.5-38) among transplant recipients and 22 (95% CI 7.1-69) among dialysis patients, compared to the background population in the same age group. Excess mortality, compared to the five years preceding the pandemic, was 30% for transplant recipients and 8.7% for dialysis patients, compared to 7.7% for the entire Swedish population. Detailed reports were sent to SRR for 864 patients with confirmed COVID-19 infection representing 5.0% of all transplant recipients and 13% of all dialysis patients. The case fatality rate was 7.0% and 21% respectively.

Translated title of the contributionCOVID-19 related mortality in Swedish patients with renal replacement therapy
Original languageSwedish
JournalLakartidningen
Volume118
Publication statusPublished - 2021 Nov 16

Subject classification (UKÄ)

  • Urology and Nephrology

Fingerprint

Dive into the research topics of 'COVID-19 related mortality in Swedish patients with renal replacement therapy'. Together they form a unique fingerprint.

Cite this